Human Genome Rejects GlaxoSmithKline’s Bid

[cnbc 3000085063]

Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC’s Herb Greenberg.

Melissa Lee anchors a fast-paced discussion among four professional Wall Street traders. An hour after the bell Fast Money hosts one of the best trading discussions of the day.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply